Payment overview · 2025
General Payments
$334.96
3 reported records · 3 companies
Healthcare provider profile · identity verified
John C Hall, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · AUSTIN, TX · NPI 1568451201
Verified facts
What the public records show
CMS Open Payments records show John C Hall, M.D. received $334.96 in general payments during 2025 across 3 reported records.
Globus Medical, Inc. accounted for 52.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Rybelsus.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 148 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 80 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Globus Medical, Inc. | Unresolved — no canonical attribution shown | $174.82 | 52.2% | 1 | 2025 |
| Inspire Medical Systems, Inc. | Unresolved — no canonical attribution shown | $145.67 | 43.5% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $14.47 | 4.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $334.96 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CREO Normalized: creo |
Device | Globus Medical, Inc. | $174.82 | 1 | 2025 |
Source payment records
|
|||||
| INSPIRE Normalized: inspire |
Device | Inspire Medical Systems, Inc. | $145.67 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $14.47 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $14.47 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 148 | exact normalized | Medicare Part D |
| Rybelsus rybelsus |
2025 | Rybelsus | 2024 | 80 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
148 | 35 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
80 | 12 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 672 | 219 |
| Levothyroxine Sodium | Levothyroxine Sodium | 578 | 174 |
| Lisinopril | Lisinopril | 452 | 147 |
| Amlodipine Besylate | Amlodipine Besylate | 427 | 139 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 343 | 110 |
| Losartan Potassium | Losartan Potassium | 303 | 109 |
| Metformin Hcl | Metformin Hcl | 291 | 92 |
| Gabapentin | Gabapentin | 277 | 86 |
| Pantoprazole Sodium | Pantoprazole Sodium | 268 | 85 |
| Omeprazole | Omeprazole | 267 | 76 |
| Ezetimibe | Ezetimibe | 265 | 88 |
| Pravastatin Sodium | Pravastatin Sodium | 225 | 75 |
| Hydrochlorothiazide | Hydrochlorothiazide | 213 | 68 |
| Metoprolol Succinate | Metoprolol Succinate | 197 | 63 |
| Farxiga | Dapagliflozin Propanediol | 191 | 38 |
| Potassium Chloride | Potassium Chloride | 188 | 64 |
| Tramadol Hcl | Tramadol Hcl | 185 | 47 |
| Alprazolam | Alprazolam | 180 | 38 |
| Allopurinol | Allopurinol | 174 | 52 |
| Tamsulosin Hcl | Tamsulosin Hcl | 160 | 53 |
| Jardiance | Empagliflozin | 155 | 33 |
| Trazodone Hcl | Trazodone Hcl | 154 | 50 |
| Ozempic | Semaglutide | 148 | 35 |
| Meloxicam | Meloxicam | 142 | 54 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 139 | 55 |
| Montelukast Sodium | Montelukast Sodium | 139 | 47 |
| Simvastatin | Simvastatin | 139 | 36 |
| Sertraline Hcl | Sertraline Hcl | 135 | 48 |
| Zolpidem Tartrate | Zolpidem Tartrate | 133 | 25 |
| Duloxetine Hcl | Duloxetine Hcl | 128 | 40 |
| Furosemide | Furosemide | 128 | 48 |
| Azithromycin | Azithromycin | 117 | 99 |
| Eliquis | Apixaban | 115 | 30 |
| Metformin Hcl Er | Metformin Hcl | 111 | 33 |
| Metoprolol Tartrate | Metoprolol Tartrate | 110 | 36 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 102 | 36 |
| Fluticasone Propionate | Fluticasone Propionate | 102 | 43 |
| Escitalopram Oxalate | Escitalopram Oxalate | 99 | 33 |
| Mounjaro | Tirzepatide | 99 | 16 |
| Methylprednisolone | Methylprednisolone | 93 | 84 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 91 | 22 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 90 | 15 |
| Finasteride | Finasteride | 83 | 26 |
| Pioglitazone Hcl | Pioglitazone Hcl | 83 | 23 |
| Rybelsus | Semaglutide | 80 | 12 |
| Donepezil Hcl | Donepezil Hcl | 79 | 27 |
| Lorazepam | Lorazepam | 78 | 17 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 76 | 60 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 75 | 25 |
| Carvedilol | Carvedilol | 74 | 28 |
| Bupropion Xl | Bupropion Hcl | 72 | 26 |
| Xarelto | Rivaroxaban | 72 | 18 |
| Pregabalin | Pregabalin | 69 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 67 | 14 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 64 | 19 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 64 | 21 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 63 | 56 |
| Citalopram Hbr | Citalopram Hydrobromide | 62 | 21 |
| Estradiol | Estradiol | 61 | 22 |
| Clopidogrel | Clopidogrel Bisulfate | 57 | 17 |
| Synthroid | Levothyroxine Sodium | 55 | 17 |
| Atenolol | Atenolol | 53 | 15 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 53 | 15 |
| Celecoxib | Celecoxib | 52 | 19 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 52 | 16 |
| Alendronate Sodium | Alendronate Sodium | 49 | 19 |
| Fluoxetine Hcl | Fluoxetine Hcl | 48 | 15 |
| Tresiba Flextouch U-200 | Insulin Degludec | 47 | suppressed |
| Myrbetriq | Mirabegron | 43 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 43 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 42 | 31 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 42 | 12 |
| Glimepiride | Glimepiride | 41 | 14 |
| Famotidine | Famotidine | 40 | 18 |
| Spironolactone | Spironolactone | 40 | 14 |
| Vascepa | Icosapent Ethyl | 40 | suppressed |
| Eszopiclone | Eszopiclone | 39 | suppressed |
| Trulicity | Dulaglutide | 39 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 38 | suppressed |
| Memantine Hcl | Memantine Hcl | 37 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 37 | 15 |
| Quetiapine Fumarate | Quetiapine Fumarate | 37 | 11 |
| Folic Acid | Folic Acid | 36 | 12 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 35 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 35 | 11 |
| Clonazepam | Clonazepam | 35 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 35 | suppressed |
| Linzess | Linaclotide | 35 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 34 | 24 |
| Topiramate | Topiramate | 34 | 11 |
| Benazepril Hcl | Benazepril Hcl | 33 | suppressed |
| Glipizide Er | Glipizide | 33 | suppressed |
| Ketoconazole | Ketoconazole | 33 | 18 |
| Hydralazine Hcl | Hydralazine Hcl | 32 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 32 | 12 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 30 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 30 | 21 |
| Bupropion Hcl Sr | Bupropion Hcl | 28 | suppressed |
| Glipizide | Glipizide | 28 | 12 |
| Paxlovid | Nirmatrelvir/Ritonavir | 28 | 27 |
| Dapagliflozin | Dapagliflozin Propanediol | 27 | 13 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 27 | 11 |
| Valacyclovir | Valacyclovir Hcl | 27 | 20 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 26 | 22 |
| Irbesartan | Irbesartan | 26 | suppressed |
| Ondansetron Odt | Ondansetron | 26 | 12 |
| Repatha Sureclick | Evolocumab | 26 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 26 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Amoxicillin | Amoxicillin | 25 | 15 |
| Levetiracetam | Levetiracetam | 24 | suppressed |
| Novolog Flexpen | Insulin Aspart | 24 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 24 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 23 | suppressed |
| Ibuprofen | Ibuprofen | 23 | suppressed |
| Colchicine | Colchicine | 22 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 22 | suppressed |
| Fenofibrate | Fenofibrate | 21 | suppressed |
| Prednisone | Prednisone | 21 | 13 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 21 | suppressed |
| Cephalexin | Cephalexin | 20 | 17 |
| Mupirocin | Mupirocin | 20 | 18 |
| Propranolol Hcl | Propranolol Hcl | 20 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 20 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 20 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 19 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 19 | 15 |
| Acyclovir | Acyclovir | 18 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 18 | suppressed |
| Baclofen | Baclofen | 18 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 18 | 16 |
| Diazepam | Diazepam | 18 | suppressed |
| Mirtazapine | Mirtazapine | 18 | suppressed |
| Modafinil | Modafinil | 18 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 18 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 18 | suppressed |
| Nifedipine Er | Nifedipine | 17 | suppressed |
| Nystatin | Nystatin | 17 | 11 |
| Torsemide | Torsemide | 17 | suppressed |
| Cilostazol | Cilostazol | 16 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 16 | 11 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 16 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 16 | suppressed |
| Levofloxacin | Levofloxacin | 16 | 11 |
| Nebivolol Hcl | Nebivolol Hcl | 16 | suppressed |
| Primidone | Primidone | 16 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 16 | suppressed |
| Testosterone | Testosterone | 16 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 15 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 15 | suppressed |
| Valsartan | Valsartan | 15 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 15 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 14 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Levemir Flexpen | Insulin Detemir | 14 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 14 | suppressed |
| Ramipril | Ramipril | 14 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 13 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 13 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Fluconazole | Fluconazole | 13 | 11 |
| Glyburide | Glyburide | 13 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 13 | suppressed |
| Prempro | Estrogen,con/M-Progest Acet | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 12 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 12 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Januvia | Sitagliptin Phosphate | 12 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Xanax | Alprazolam | 12 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 12 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 11 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 11 | suppressed |
| Etodolac | Etodolac | 11 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 11 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 11 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $334.96 · 3 records | Globus Medical, Inc. | CREO, INSPIRE, Ozempic, Rybelsus | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error